Shih‐Chung Chang
About
Shih‐Chung Chang has authored 42 papers that have received a total of 2.8k indexed citations.
This includes 15 papers in Molecular Biology, 15 papers in Infectious Diseases and 11 papers in Epidemiology. The topics of these papers are Peptidase Inhibition and Analysis (8 papers), Ubiquitin and proteasome pathways (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Shih‐Chung Chang is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), Ubiquitin and proteasome pathways (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers) and collaborates with scholars based in Taiwan, United States and Greece. Shih‐Chung Chang's co-authors include Alfred L. Goldberg, Rong‐Huay Juang, Hui‐Wen Chen, Sui‐Yuan Chang and Chia‐Jung Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Immunology and Molecular Cell.
In The Last Decade
side by side view
Countries citing papers authored by Shih‐Chung Chang
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by R. Jaeger Breakdown of academic impact, for papers by Eugene Melamud Breakdown of academic impact, for papers by David E. Heppner Breakdown of academic impact, for papers by David R. Wekstein Breakdown of academic impact, for papers by Li‐Fern Hsu Breakdown of academic impact, for papers by Jim Constantz Breakdown of academic impact, for papers by Peer‐Hendrik Kuhn Breakdown of academic impact, for papers by Moria Golan